Skip to main content
. Author manuscript; available in PMC: 2023 Jan 13.
Published in final edited form as: Biomark Neuropsychiatry. 2019 Oct 30;1:100002. doi: 10.1016/j.bionps.2019.100002

Fig. 5.

Fig. 5.

Final Component values for each of the 5 significant components (Delta, Alpha, Beta, & Gamma Power and Alpha dbWPLI). See supplemental Figs. 1 and 2 for frequency and spatial PCA weights. Each component showed a highly similar pattern for DSM (HC and probands showed a similar response) and Biotype groupings (B2 > HC/B3> B1). A) Values sorted by DSM categories. HC, Healthy Comparison subjects (n = 218); SZ, probands with schizophrenia (n = 223); SAD, probands with schizoaffective disorder (n = 130); BDP, probands with bipolar disorder I with psychosis (n = 178). B) HC, Healthy Comparison subjects (n = 218); B1, Biotype-1 (n = 148); B2, Biotype-2 (n = 169); B3, Biotype-3 (n = 214). Values are in standardized units. Error bars = SEM.